Principles of medical management in chronic open angle glaucoma.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001082:Aqueous Humor / Q000502:physiology; D002217:Carbachol / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002301:Cardiac Glycosides / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D002940:Circadian Rhythm; D004234:Diuretics, Osmotic / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008875:Middle Aged; D008916:Miotics / Q000627:therapeutic use*; D010830:Physostigmine / Q000009:adverse effects / Q000627:therapeutic use; D010862:Pilocarpine / Q000009:adverse effects / Q000627:therapeutic use; D014794:Visual Fields
D002257:Carbonic Anhydrase Inhibitors; D002301:Cardiac Glycosides; D002800:Cholinesterase Inhibitors; D004234:Diuretics, Osmotic; D008916:Miotics; D010862:Pilocarpine; D002217:Carbachol; D010830:Physostigmine; D004837:Epinephrine